Sugimura M - Search Results

1

Clinical significance of urokinase-type plasminogen activator (uPA) in invasive cervical cancer of the uterus.

Sugimura M, Kobayashi H, Kanayama N, Terao T. Sugimura M, et al. Gynecol Oncol. 1992 Sep;46(3):330-6. doi: 10.1016/0090-8258(92)90227-a. Gynecol Oncol. 1992. PMID: 1526511

2

Characterization and clinical evaluation of tumor-associated antigen CA54/61 identified by monoclonal antibodies MA54 and MA61 in epithelial ovarian cancer.

Kobayashi H, Ohi H, Sugimura M, Shinohara H, Terao T. Kobayashi H, et al. Among authors: sugimura m. Gynecol Oncol. 1992 Dec;47(3):328-36. doi: 10.1016/0090-8258(92)90135-6. Gynecol Oncol. 1992. PMID: 1473746

3

[Immunohistochemical study on the expression of epidermal growth factor receptor (EGF-R) in invasive cervical cancer of the uterus].

Sugimura M, Kobayashi H, Kanayama N, Terao T. Sugimura M, et al. Nihon Sanka Fujinka Gakkai Zasshi. 1992 Jun;44(6):689-94. Nihon Sanka Fujinka Gakkai Zasshi. 1992. PMID: 1506731 Japanese.

4

Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B.

Kobayashi H, Ohi H, Sugimura M, Shinohara H, Fujii T, Terao T. Kobayashi H, et al. Among authors: sugimura m. Cancer Res. 1992 Jul 1;52(13):3610-4. Cancer Res. 1992. PMID: 1617632

5

Plasmin modulators, aprotinin and anti-catalytic plasmin antibody, efficiently inhibit destruction of bovine vascular endothelial cells by choriocarcinoma cells.

Sugimura M, Kobayashi H, Terao T. Sugimura M, et al. Gynecol Oncol. 1994 Mar;52(3):337-46. doi: 10.1006/gyno.1994.1059. Gynecol Oncol. 1994. PMID: 7512520

6

Effects of urinary trypsin inhibitor on the invasion of reconstituted basement membranes by ovarian cancer cells.

Kobayashi H, Fujie M, Shinohara H, Ohi H, Sugimura M, Terao T. Kobayashi H, et al. Among authors: sugimura m. Int J Cancer. 1994 May 1;57(3):378-84. doi: 10.1002/ijc.2910570315. Int J Cancer. 1994. PMID: 8168999

7

Role of activated protein C in facilitating basement membrane invasion by tumor cells.

Kobayashi H, Moniwa N, Gotoh J, Sugimura M, Terao T. Kobayashi H, et al. Among authors: sugimura m. Cancer Res. 1994 Jan 1;54(1):261-7. Cancer Res. 1994. PMID: 8261450

8

Increased cell-surface urokinase in advanced ovarian cancer.

Kobayashi H, Moniwa N, Sugimura M, Shinohara H, Ohi H, Terao T. Kobayashi H, et al. Among authors: sugimura m. Jpn J Cancer Res. 1993 Jun;84(6):633-40. doi: 10.1111/j.1349-7006.1993.tb02023.x. Jpn J Cancer Res. 1993. PMID: 8340251 Free PMC article.

9

Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.

Kobayashi H, Ohi H, Shinohara H, Sugimura M, Fujii T, Terao T, Schmitt M, Goretzki L, Chucholowski N, Jänicke F, et al. Kobayashi H, et al. Among authors: sugimura m. Br J Cancer. 1993 Mar;67(3):537-44. doi: 10.1038/bjc.1993.99. Br J Cancer. 1993. PMID: 8382511 Free PMC article.

10

Monoclonal antibodies MA54 and MA61 as potential reagents in the prognosis of patients with ovarian cancer.

Kobayashi H, Ohi H, Sugimura M, Shinohara H, Terao T. Kobayashi H, et al. Among authors: sugimura m. Gynecol Oncol. 1993 Apr;49(1):80-5. doi: 10.1006/gyno.1993.1090. Gynecol Oncol. 1993. PMID: 8482565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters